Recombinant Proteins
- (2)
- (970)
- (1)
- (23,543)
- (5)
- (1)
- (1)
- (67)
- (219)
- (4,424)
- (23)
- (1)
- (4)
- (2)
- (13)
- (21,461)
- (3)
- (4)
- (3)
- (1)
- (2)
- (4)
- (14)
- (71)
- (2)
- (2)
- (2)
- (1)
- (3)
- (2)
- (1)
- (3)
- (4)
- (1)
- (1)
- (1)
- (3)
- (254)
- (22,606)
- (1)
- (1)
- (2)
- (1)
- (13)
- (26,166)
- (256)
- (32)
- (3)
- (708)
- (14)
- (2)
- (1)
- (8)
- (1)
- (5)
- (1)
- (108)
- (1)
- (3,782)
- (1,408)
- (3)
- (4)
- (2)
- (5)
- (1)
- (1)
- (1)
- (1)
- (14)
- (138)
- (48)
- (6)
- (17)
- (2)
- (1)
- (4)
- (81)
- (12)
- (2)
- (3)
- (80)
- (4)
- (113)
- (96)
- (19)
- (1)
- (1)
- (4)
- (1)
- (1,522)
- (2)
- (1)
- (3)
- (18)
- (48)
- (3)
- (1)
- (2)
- (9)
- (27)
- (2)
- (191)
- (1)
- (4)
- (1)
- (2)
- (114)
- (44)
- (2)
- (1)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (23,710)
- (6)
- (3)
- (1)
- (1)
- (63)
- (6)
- (2)
- (7)
- (5)
- (1)
- (2)
- (1)
- (1)
- (6,728)
- (6)
- (4)
- (1)
- (3)
- (1)
- (3)
- (2)
- (13)
- (17)
- (1)
- (3)
- (3)
- (4)
- (25,926)
- (240)
- (1)
- (3)
- (286)
- (2)
- (61,741)
- (1)
- (15)
- (1)
- (2)
- (45,213)
- (5,693)
- (245)
- (168)
- (56)
- (3,364)
- (2)
- (1)
- (2)
- (1)
- (21)
- (558)
- (96)
- (2)
- (1)
- (1)
- (2)
- (1)
- (27)
- (1)
- (8)
- (15)
- (1)
- (72)
- (1)
- (1,042)
- (1)
- (3)
- (16)
- (1)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (4)
- (1)
- (1)
- (26,017)
- (5)
- (1)
- (4)
- (582)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (14)
- (32)
- (24)
- (1)
- (2)
- (16)
- (120)
- (9)
- (2)
- (1)
- (2)
- (2)
- (2)
- (23)
- (5)
- (3)
- (3)
- (2)
- (14)
- (23,574)
- (1)
- (48)
- (7)
- (1)
- (3)
- (18)
- (2)
- (62)
- (1)
- (4)
- (2)
- (9)
- (59)
- (1)
- (2)
- (3)
- (1)
- (391)
- (1)
- (3)
- (2)
- (1)
- (1)
- (1)
- (3)
- (2)
- (6)
- (19)
- (7)
- (2)
- (2)
- (3)
- (45)
- (1)
- (1)
- (1)
- (2)
- (5)
- (1)
- (1)
- (1)
- (1)
- (2)
- (8)
- (2)
- (3)
- (38,945)
- (1)
- (11)
Filtered Search Results
R&D Systems™ Recombinant Human CRELD1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
R&D Systems™ Recombinant Mouse IL-23R Fc Chimera Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity
BD Recombinant Erythropoietin (EPO) Protein
Determined by SDS-PAGE and an absorbance assay based on Beers-Lambert law
| Regulatory Status | RUO |
|---|---|
| Purity or Quality Grade | >95%, by SDS-PAGE under reducing conditions |
| Conjugate | Unconjugated |
| Form | Liquid |
| Molecular Weight (g/mol) | 38 kDa |
| Formulation | 0.01 M Bis-tris propane with 0.1 M NaCl, 50% glycerol and no preservative; pH 9.0 |
| Sequence | Amino acids Met1- Glu303 containing an N-terminal His-tag |
| Concentration | 0.081 mg/mL |
| For Use With (Application) | Control,Western Blot |
| Source | E. coli |
| Name | Human CDK4 |
| Recombinant | Recombinant |
| Content And Storage | -20°C, Avoid Freeze/Thaw Cycles |
|---|---|
| Purity or Quality Grade | ≥90% as determined by SDS-PAGE. ≥95% as determined by SEC-HPLC |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | CD4 |
| Molecular Weight (g/mol) | 42.14 kDa |
| Gene Symbol | CD4 |
| Activity | Measured by the ability of the immobilized protein to support the adhesion of NIH-3T3 mouse embryonic fibroblast cells. When cells are added to CD4-coated plates (0.8 μg/mL, 100 μL/well), approximately >40% will adhere specifically. |
| Sequence | Met1-Trp390 |
| Concentration | 0.25 mg/mL |
| Expression System | HEK293 cells |
| For Use With (Application) | Control,ELISA Standard,Binding Assay |
| Name | Human CD4 His-tag |
| Accession Number | P01730 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | Activation B7-1 antigen; B7; B7.1; B7-1; BB1; B-lymphocyte activation antigen B7; CD28LG; CD28LG1; CD4; CD4 antigen; CD4 antigen (p55); CD4 antigen p55; Cd4 molecule; CD4 precursor; CD4 receptor; CD4, allele 1; cd4a; CD4mut; CD80; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); CD80 molecule; cell surface glycoprotein CD4; costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; fCD4; L3T4; LAB7; Leu-3; Ly-4; lymphocyte antigen CD4; lymphocyte antigen CD4 precursor; membrane protein; p55; T-cell differentiation antigen L3T4; T-cell surface antigen T4/Leu-3; T-cell surface glycoprotein CD4; T-cell surface glycoprotein CD4 precursor (T-cell surface antigen T4/Leu-3) (T-cell differentiation antigen L3T4); T-lymphocyte activation antigen CD80; W3/25; W3/25 antigen |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Measured by the ability of the immobilized protein to support the adhesion of NIH-3T3 mouse embryonic fibroblast cells. When cells are added to CD4-coated plates (0.8 μg/mL, 100 μL/well), approximately >40% will adhere specifically. |
| Gene ID (Entrez) | 920 |
| Formulation | PBS with 5% mannitol, 5% trehalose, 0.01% Tween 80 and no preservative; pH 7.4 |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥95% |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 7.5 |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 16.9 kDa |
| Common Name | IFN gamma |
| Gene Symbol | IFNG |
| Activity | ED50 <0.75 ng/mL; determined in Viral challenge assay using EMC virus on A549 cells |
| Endotoxin Concentration | ≤0.1 EU/μg |
| Storage Requirements | -20°C, Avoid Freeze/Thaw Cycles |
| Sequence | MQDPYVKEAE NLKKYFNAGH SDVADNGTLF LGILKNWKEE SDRKIMQSQI VSFYFKLFKN FKDDQSIQKS VETIKEDMNV KFFNSNKKKR DDFEKLTNYS VTDLNVQRKA IHELIQVMAE LSPAAKTGKR KRSQMLFQGR RASQ |
| Concentration | 0.1 mg/mL |
| Expression System | E. coli |
| For Use With (Application) | Control,Bioactivity |
| Name | Human IFN-gamma |
| Accession Number | P01579 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | BoIFNG; cytokine; EGK_03901; gamma interferon; gamma interferon precursor; gamma-interferon; gamma-interferon precursor (AA -23 to 143); H-IFN-g; IFG; IFI; IFN gamma; IFN γ; Ifng; IFN-g; IFNG2; IFN-gamma; IFN-gamma precursor; IFN-y; IFNγ; Immune interferon; Interferon; interferon gamma; interferon gamma precursor; interferon gamma type 2; Interferon y; Interferon γ; interferon, gamma; interferon-gama; interferon-gamma; Interferon-gamma level; interferon-gamma precursor; Interferonγ; M-IFN-g; R-IFN-g |
| Product Type | Protein |
| Gene ID (Entrez) | 3458 |
| Formulation | 10mM sodium phosphate with 50mM NaCl and no preservative; pH 7.5 |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥90% as determined by SDS-PAGE, ≥90% as determined by SEC-HPLC |
|---|---|
| Conjugate | Unconjugated |
| pH Range | 7.5 |
| Form | Liquid |
| Molecular Weight (g/mol) | 114.5 kDa |
| Common Name | PARP1 |
| Gene Symbol | Parp1 |
| Endotoxin Concentration | <1.0 EU/μg |
| Storage Requirements | -20°C, Avoid Freeze/Thaw Cycles |
| Sequence | Human PARP1, amino acids Met1-Trp1014 (Accession # NP_001609.2) with a C-terminal His-tag |
| Concentration | 1.1 mg/mL |
| Expression System | Baculovirus |
| For Use With (Application) | Control,Neutralization |
| Name | Human PARP1 His-tag |
| Accession Number | P09874 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | 5830444G22Rik; ADP-ribosyltransferase (NAD+; ADP-ribosyltransferase (NAD+) poly (ADP-ribose) polymerase); ADP-ribosyltransferase (NAD+, poly (ADP-ribose) polymerase) 1; ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase); ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase) 1; ADP-ribosyltransferase 1; ADP-ribosyltransferase diphtheria toxin-like 1; ADP-ribosyltransferase NAD(+); Adprp; Adprt; ADPRT 1; Adprt1; AI893648; ARTD1; C80510; DNA ADP-ribosyltransferase PARP1; I79_014850; msPARP; NAD(+) ADP-ribosyltransferase 1; NAD(+) pADPRT-1; pADPRT-1; PARP; PARP1; PARP-1; poly (ADP-ribose) polymerase 1; poly (ADP-ribose) polymerase family, member 1; poly (ADP-ribose) polymerase); poly [ADP-ribose] polymerase 1; poly ADP-ribose polymerase; poly(ADP-ribose) polymerase; poly(ADP-ribose) polymerase 1; poly(ADP-ribose) polymerase PARP-1; poly(ADP-ribose) synthetase; poly(ADP-ribosyl)transferase; Poly[ADP-ribose] synthase 1; poly[ADP-ribose] synthetase 1; PPOL; Protein poly-ADP-ribosyltransferase PARP1; sPARP-1; synthetase fragment (AA 67); Unknown (protein for IMAGE:8023736); unnamed protein product |
| Product Type | Protein |
| Gene ID (Entrez) | 142 |
| Formulation | 20mM tris with 300mM NaCl, 2mM EDTA, 10% glycerol, 0.5mM TCEP and no preservative; pH 7.5 |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
R&D Systems™ Recombinant Mouse Galectin-1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 15 kDa |
| Gene ID (Entrez) | 16852 |
| Quantity | 50 μg |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | E. coli-derived mouse Galectin-1 protein Ala2-Glu135 |
| Recombinant | Recombinant |
| Name | Galectin-1 |
Novus Biologicals™ Recombinant Human FKBP6 His Protein
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Highly purified and high bioactivity. Generating reliable and reproducible results. Applications: Functional, SDS-Page, Bioactivity
R&D Systems™ Recombinant Mouse Siglec-15 His-tag Protein
Measured by its ability to inhibit IL-2 secretion by mouse T cells in the presence of anti-CD3. The ED50 for this effect is 0.075 to 0.75 μg/mL.
R&D Systems™ Recombinant Mouse DLL4 His-tag Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Mouse B7-H3 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. (Observed): 38-45 kDa, reducing conditions; M.W. (theoretical): 24.8 kDa |
| Gene Symbol | Cd276 |
| Quantity | 50 μg |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | B7-H3/CD276 |
| Source | Mouse myeloma cell line, NS0-derived mouse B7-H3 protein Val29-Phe244, with a C-terminal 10-His tag |
| Name | B7-H3 |
| Accession Number | Q8VE98.1 |
| Gene ID (Entrez) | 80381 |
| Recombinant | Recombinant |
| Regulatory Status | RUO |
|---|---|
| Purity or Quality Grade | >95%, by SDS-PAGE under reducing conditions |
| Conjugate | Unconjugated |
| Form | Liquid |
| Formulation | 0.02 M tris HCl with 1 mM EDTA, 50% glycerol and no preservative; pH 8 |
| Sequence | Amino acids Gly311- Ser426 containing an N-terminal His-tag |
| Concentration | 0.153 mg/mL |
| For Use With (Application) | Control,Western Blot |
| Source | E. coli |
| Name | Human Activin A |
| Recombinant | Recombinant |